CAPROCK Group Inc. Boosts Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

CAPROCK Group Inc. boosted its holdings in HCA Healthcare, Inc. (NYSE:HCAGet Rating) by 1.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,027 shares of the company’s stock after buying an additional 59 shares during the quarter. CAPROCK Group Inc.’s holdings in HCA Healthcare were worth $1,009,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the stock. NuWave Investment Management LLC increased its holdings in HCA Healthcare by 220.3% in the first quarter. NuWave Investment Management LLC now owns 4,362 shares of the company’s stock valued at $1,093,000 after buying an additional 3,000 shares during the last quarter. Insight Wealth Strategies LLC purchased a new position in shares of HCA Healthcare during the first quarter worth about $2,031,000. Veriti Management LLC grew its holdings in shares of HCA Healthcare by 4.0% during the first quarter. Veriti Management LLC now owns 1,297 shares of the company’s stock worth $325,000 after purchasing an additional 50 shares during the last quarter. Atalanta Sosnoff Capital LLC purchased a new position in shares of HCA Healthcare during the first quarter worth about $20,094,000. Finally, Nordea Investment Management AB grew its holdings in shares of HCA Healthcare by 6.3% during the first quarter. Nordea Investment Management AB now owns 612,002 shares of the company’s stock worth $155,602,000 after purchasing an additional 36,017 shares during the last quarter. 67.87% of the stock is currently owned by hedge funds and other institutional investors.

Shares of HCA opened at $176.59 on Thursday. The company has a debt-to-equity ratio of 87.46, a current ratio of 1.43 and a quick ratio of 1.24. The firm has a 50 day simple moving average of $212.58 and a 200-day simple moving average of $237.66. HCA Healthcare, Inc. has a 1-year low of $169.13 and a 1-year high of $279.02. The stock has a market cap of $52.18 billion, a price-to-earnings ratio of 8.31, a price-to-earnings-growth ratio of 1.11 and a beta of 1.61.

HCA Healthcare (NYSE:HCAGet Rating) last issued its quarterly earnings data on Friday, April 22nd. The company reported $4.12 earnings per share for the quarter, missing analysts’ consensus estimates of $4.27 by ($0.15). HCA Healthcare had a return on equity of 405.72% and a net margin of 11.40%. The business had revenue of $14.95 billion for the quarter, compared to analysts’ expectations of $14.72 billion. During the same period last year, the business earned $4.14 earnings per share. The company’s revenue for the quarter was up 6.9% on a year-over-year basis. On average, equities analysts expect that HCA Healthcare, Inc. will post 17.12 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 30th. Shareholders of record on Thursday, June 16th will be paid a $0.56 dividend. The ex-dividend date of this dividend is Wednesday, June 15th. This represents a $2.24 annualized dividend and a yield of 1.27%. HCA Healthcare’s payout ratio is currently 10.54%.

A number of equities analysts recently issued reports on the company. UBS Group lowered their price target on HCA Healthcare from $289.00 to $241.00 and set a “buy” rating on the stock in a report on Tuesday, April 26th. Cowen lowered their price target on HCA Healthcare from $265.00 to $241.00 in a report on Monday, April 25th. Raymond James lowered their price target on HCA Healthcare from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Tuesday, April 26th. Loop Capital initiated coverage on shares of HCA Healthcare in a research report on Thursday, June 16th. They issued a “buy” rating and a $240.00 price objective for the company. Finally, Oppenheimer set a $255.00 price objective on shares of HCA Healthcare in a research report on Monday. Five equities research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $257.68.

In related news, major shareholder Thomas F. Frist, Jr. acquired 89,100 shares of the stock in a transaction dated Monday, May 2nd. The stock was bought at an average cost of $211.93 per share, with a total value of $18,882,963.00. Following the purchase, the insider now directly owns 478,955 shares of the company’s stock, valued at $101,504,933.15. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Jennifer Berres sold 2,358 shares of the business’s stock in a transaction on Friday, May 13th. The shares were sold at an average price of $218.87, for a total transaction of $516,095.46. Following the sale, the senior vice president now directly owns 11,392 shares of the company’s stock, valued at $2,493,367.04. The disclosure for this sale can be found here. Insiders acquired a total of 91,370 shares of company stock valued at $19,373,375 over the last ninety days. 1.50% of the stock is owned by corporate insiders.

HCA Healthcare Profile (Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAGet Rating).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.